Vancomycin-resistant enterococci colonisation, risk factors and risk for infection among hospitalised paediatric patients: a systematic review and meta-analysis

International Journal of Antimicrobial Agents

Volumn 49, Issue 5, 2017, Pages 565-572

  Flokas, Myrto Eleni ^a   Karageorgos, Spyridon A ^a   Detsis, Marios ^a   Alevizakos, Michail ^a   Mylonakis, Eleftherios ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Colonisation; Paediatric; Vancomycin resistant enterococci

Indexed keywords

CEFTAZIDIME; VANCOMYCIN; ANTIINFECTIVE AGENT;

BACTERIAL COLONIZATION; DRUG USE; ENTEROCOCCAL INFECTION; GASTROINTESTINAL TRACT; HEMATOLOGY; HIGH RISK POPULATION; HOSPITALIZED CHILD; HUMAN; INFECTION CONTROL; INFECTION RISK; META ANALYSIS; NONHUMAN; ONCOLOGY; PEDIATRIC INTENSIVE CARE UNIT; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; VANCOMYCIN RESISTANT ENTEROCOCCUS; CHILD; CROSS INFECTION; DRUG EFFECTS; GRAM POSITIVE INFECTION; HOSPITALIZATION; MICROBIOLOGY; PRESCHOOL CHILD; VANCOMYCIN RESISTANCE;

ANTI-BACTERIAL AGENTS; CEFTAZIDIME; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; GASTROINTESTINAL TRACT; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALIZATION; HUMANS; VANCOMYCIN; VANCOMYCIN RESISTANCE; VANCOMYCIN-RESISTANT ENTEROCOCCI;

EID: 85016014950     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2017.01.008     Document Type: Review

References (70)

1. [1] Hidron, A.I., Edwards, J.R., Patel, J., Horan, T.C., Sievert, D.M., Pollock, D.A., et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 29 (2008), 996–1011.
2. [2] Sievert, D.M., Ricks, P., Edwards, J.R., Schneider, A., Patel, J., Srinivasan, A., et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol 34 (2013), 1–14.
3. [3] O'Driscoll, T., Crank, C.W., Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infect Drug Resist 8 (2015), 217–230.
4. [4] Adams, D.J., Eberly, M.D., Goudie, A., Nylund, C.M., Rising vancomycin-resistant Enterococcus infections in hospitalized children in the United States. Hosp Pediatr 6 (2016), 404–411.
5. [5] Prematunge, C., MacDougall, C., Johnstone, J., Adomako, K., Lam, F., Robertson, J., et al. VRE and VSE bacteremia outcomes in the era of effective VRE therapy: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 37 (2016), 26–35.
6. [6] Arias, C.A., Murray, B.E., The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol 10 (2012), 266–278.
7. [7] Cheah, A.L., Spelman, T., Liew, D., Peel, T., Howden, B.P., Spelman, D., et al. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. Clin Microbiol Infect 19 (2013), E181–9.
8. [8] Murray, B.E., Vancomycin-resistant enterococcal infections. N Engl J Med 342 (2000), 710–721.
9. [9] Peel, T., Cheng, A.C., Spelman, T., Huysmans, M., Spelman, D., Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia. Clin Microbiol Infect 18 (2012), 388–394.
10. [10] Cheah, A.L., Peel, T., Howden, B.P., Spelman, D., Grayson, M.L., Nation, R.L., et al. Case–case–control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia. BMC Infect Dis, 14, 2014, 353.
11. [11] Schouten, A.M., Hoogkamp-Korstanje, A.J.A., Meis, G.J.F., Voss, A., Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis 19 (2000), 816–822.
12. [12] Goetz, A.M., Rihs, J.D., Wagener, M.M., Muder, R.R., Infection and colonization with vancomycin-resistant Enterococcus faecium in an acute care veterans affairs medical center: a 2-year survey. Am J Infect Control 26 (1998), 558–562.
13. [13] Hutton, B., Salanti, G., Caldwell, D.M., Chaimani, A., Schmid, C.H., Cameron, C., et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162 (2015), 777–784.
14. [14] Stroup, D.F., Berlin, J.A., Morton, S.C., Olkin, I., Williamson, G.D., Rennie, D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 283 (2000), 2008–2012.
15. [15] Yameen, M.A., Iram, S., Mannan, A., Khan, S.A., Akhtar, N., Nasal and perirectal colonization of vancomycin sensitive and resistant enterococci in patients of paediatrics ICU (PICU) of tertiary health care facilities. BMC Infect Dis, 13, 2013, 156.
16. [16] Singh-Naz, N., Sleemi, A., Pikis, A., Patel, K.M., Campos, J.M., Vancomycin-resistant Enterococcus faecium colonization in children. J Clin Microbiol 37 (1999), 413–416.
17. [17] Reale, A., Depetri, M., Culasso, C., Paviolo, M., Cheguirián, M., Enrico, M., et al. Vancomycin-resistant enterococci: prevalence and factors associated with intestinal colonization in oncology patients from Hospital de Niños de Córdoba. Rev Argent Microbiol 41 (2009), 92–96 in Spanish.
18. [18] Willems, R.J., Top, J., van Santen, M., Robinson, D.A., Coque, T.M., Baquero, F., et al. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 11 (2005), 821–828.
19. [19] Cheng, V.C., Chen, J.H., Tai, J.W., Wong, S.C., Poon, R.W., Hung, I.F., et al. Decolonization of gastrointestinal carriage of vancomycin-resistant Enterococcus faecium: case series and review of literature. BMC Infect Dis, 14, 2014, 514.
20. [20] Ekuma, A.E., Oduyebo, O.O., Efunshile, A.M., Konig, B., Surveillance for vancomycin resistant enterococci in a tertiary institution in south western Nigeria. Afr J Infect Dis 10 (2016), 121–126.
21. [21] Christenson, J.C., Korgenski, E.K., Jenkins, E., Daly, J.A., Detection of vancomycin-resistant enterococci colonization in a children's hospital. Am J Infect Control 26 (1998), 569–571.
22. [22] Henning, K.J., Delencastre, H., Eagan, J., Boone, N., Brown, A., Chung, M., et al. Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. Pediatr Infect Dis J 15 (1996), 848–854.
23. [23] Milstone, A.M., Song, X., Beers, C., Berkowitz, I., Carroll, K.C., Perl, T.M., Unrecognized burden of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus carriage in the pediatric intensive care unit. Infect Control Hosp Epidemiol 29 (2008), 1174–1176.
24. [24] Milstone, A.M., Maragakis, L.L., Carroll, K.C., Perl, T.M., Targeted surveillance to identify children colonized with vancomycin-resistant Enterococcus in the pediatric intensive care unit. Infect Control Hosp Epidemiol 31 (2010), 95–98.
25. [25] Trabulsi, A., Glover, A.-M., Reising, S.F., Christie, C.D., Absence of rectal colonization with vancomycin-resistant enterococci among high-risk pediatric patients. Infect Control Hosp Epidemiol 19 (1998), 109–111.
26. [26] Tresoldi, A.T., Cardoso, L.G.O., Castilho, G.V., Dantas, S.R.P.E., von Nowakonski, A., Pereira, R.M., et al. Low prevalence of vancomycin resistant enterococci colonization in intensive care patients in a Brazilian teaching hospital. Braz J Infect Dis 10 (2006), 239–241.
27. [27] Akturk, H., Sutcu, M., Somer, A., Acar, M., Akgun Karapınar, B., Aydin, D., et al. Vancomycin-resistant enterococci colonization in a neonatal intensive care unit: who will be infected?. J Matern Fetal Neonatal Med 29 (2016), 3478–3482.
28. [28] Gozaydin, A., Kose, S., Ece, G., Ersan, G., Gonullu, M., Detection of vancomycin resistant enterococci from rectal swab samples by Becton-Dickinson GeneOhm VanR assay and culture at ICU of a tertiary care center in Turkey. Pak J Med Sci 29 (2013), 682–686.
29. [29] Özkaya-Parlakay, A., Cengiz, A.B., Ceyhan, M., Bağdat, A., Barın-Kurtoğlu, Ç., Gürbüz, V., et al. Vancomycin-resistant Enterococcus colonization and infection in children: six-year follow-up. Turk J Pediatr 56 (2014), 618–625.
30. [30] Sutcu, M., Akturk, H., Acar, M., Salman, N., Aydin, D., Akgun Karapınar, B., et al. Impact of vancomycin-resistant enterococci colonization in critically ill pediatric patients. Am J Infect Control 44 (2016), 515–519.
31. [31] Ulu-Kilic, A., Ozhan, E., Altun, D., Percin, D., Gunes, T., Alp, E., Is it worth screening for vancomycin-resistant Enterococcus faecium colonization?: financial burden of screening in a developing country. Am J Infect Control 44 (2016), e45–9.
32. [32] Yüce, A., Karaman, M., Gülay, Z., Yulug, N., Vancomycin-resistant enterococci in neonates. Scand J Infect Dis 33 (2001), 803–805.
33. [33] Hufnagel, M., Liese, C., Loescher, C., Kunze, M., Proempeler, H., Berner, R., et al. Enterococcal colonization of infants in a neonatal intensive care unit: associated predictors, risk factors and seasonal patterns. BMC Infect Dis 7 (2007), 1–11.
34. [34] Gray, J.W., George, R.H., Experience of vancomycin-resistant enterococci in a children's hospital. J Hosp Infect 45 (2000), 11–18.
35. [35] Briggs, S., Upton, A., Bilkey, M., Taylor, S., Roberts, S., Holland, D., Vancomycin-resistant enterococcal colonisation of hospitalised patients in Auckland. N Z Med J, 115, 2002, U145.
36. [36] Wells, G.A., Shea, B., O'Connell, D., Peterson, J., Welch, V., Losos, M., et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp [Accessed 10 May 2016].
37. [37] DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Control Clin Trials 7 (1986), 177–188.
38. [38] Nyaga, V.N., Arbyn, M., Aerts, M., Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health, 72, 2014, 39.
39. [39] Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997), 629–634.
40. 2 in assessing heterogeneity may mislead. BMC Med Res Methodol, 8, 2008, 79.
41. [41] Thompson, S.G., Higgins, J.P., How should meta-regression analyses be undertaken and interpreted?. Stat Med 21 (2002), 1559–1573.
42. [42] Flokas, M.E., Detsis, M., Alevizakos, M., Mylonakis, E., Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections: a systematic review and meta-analysis. J Infect 73 (2016), 547–557.
43. [43] Reitsma, J.B., Glas, A.S., Rutjes, A.W., Scholten, R.J., Bossuyt, P.M., Zwinderman, A.H., Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58 (2005), 982–990.
44. [44] Rutter, C.M., Gatsonis, C.A., A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 20 (2001), 2865–2884.
45. [45] McGee, S., Simplifying likelihood ratios. J Gen Intern Med 17 (2002), 647–650.
46. [46] Gedik, H., Yildirmak, T., Simsek, F., Kanturk, A., Arica, D., Aydin, D., et al. Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies. J Infect Dev Ctries 8 (2014), 1113–1118.
47. [47] Ford, C.D., Lopansri, B.K., Haydoura, S., Snow, G., Dascomb, K.K., Asch, J., et al. Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukemia: different patterns in patients with acute myelogenous and acute lymphoblastic leukemia. Infect Control Hosp Epidemiol 36 (2015), 47–53.
48. [48] Liss, B.J., Vehreschild, J.J., Cornely, O.A., Hallek, M., Fatkenheuer, G., Wisplinghoff, H., et al. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection 40 (2012), 613–619.
49. [49] Mioljević, V., Marković-Denić, L., Vidović, A., Jovanović, M., Tosić, T., Tomin, D., Risk factors for vancomycin-resistant Enterococcus colonization in hematologic patients. Vojnosanit Pregl 70 (2013), 1109–1116.
50. [50] Montecalvo, M.A., de Lencastre, H., Carraher, M., Gedris, C., Chung, M., VanHorn, K., et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 16 (1995), 680–685.
51. [51] Kamboj, M., Chung, D., Seo, S.K., Pamer, E.G., Sepkowitz, K.A., Jakubowski, A.A., et al. The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Biol Blood Marrow Transplant 16 (2010), 1576–1581.
52. [52] Ziakas, P.D., Thapa, R., Rice, L.B., Mylonakis, E., Trends and significance of VRE colonization in the ICU: a meta-analysis of published studies. PLoS ONE, 8, 2013 e75658.
53. [53] European Centre for Disease Prevention and Control, Antimicrobial resistance surveillance in Europe 2012. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm, Sweden: ECDC; Available from: http://ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-surveillance-europe-2012.pdf, 2013 [Accessed 14 March 2017].
54. [54] Abat, C., Raoult, D., Rolain, J.M., Low level of resistance in enterococci isolated in four hospitals, Marseille, France. Microb Drug Resist 22 (2016), 218–222.
55. [55] Satilmis, L., Vanhems, P., Benet, T., Outbreaks of vancomycin-resistant enterococci in hospital settings: a systematic review and calculation of the basic reproductive number. Infect Control Hosp Epidemiol 37 (2016), 289–294.
56. [56] Zacharioudakis, I.M., Zervou, F.N., Ziakas, P.D., Rice, L.B., Mylonakis, E., Vancomycin-resistant enterococci colonization among dialysis patients: a meta-analysis of prevalence, risk factors, and significance. Am J Kidney Dis 65 (2015), 88–97.
57. [57] Keyserling, H.L., Sinkowitz-Cochran, R.L., Harris, J.M. 2nd, Levine, G.L., Siegel, J.D., Stover, B.H., et al. Vancomycin use in hospitalized pediatric patients. Pediatrics 112 (2003), e104–11.
58. [58] Kline, R.M., Baorto, E.P., Treatment of pediatric febrile neutropenia in the era of vancomycin-resistant microbes. Pediatr Blood Cancer 44 (2005), 207–214.
59. [59] Harbarth, S., Cosgrove, S., Carmeli, Y., Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother 46 (2002), 1619–1628.
60. [60] Patel, S.J., Oshodi, A., Prasad, P., Delamora, P., Larson, E., Zaoutis, T., et al. Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12 step campaign to prevent antimicrobial resistance. Pediatr Infect Dis J 28 (2009), 1047–1051.
61. [61] Levy, E.R., Swami, S., Dubois, S.G., Wendt, R., Banerjee, R., Rates and appropriateness of antimicrobial prescribing at an academic children's hospital, 2007–2010. Infect Control Hosp Epidemiol 33 (2012), 346–353.
62. [62] Bolon, M.K., Arnold, A.D., Feldman, H.A., Rehkopf, D.H., Strong, E.F., Goldmann, D.A., et al. Evaluating vancomycin use at a pediatric hospital: new approaches and insights. Infect Control Hosp Epidemiol 26 (2005), 47–55.
63. [63] Smith, M.J., Gerber, J.S., Hersh, A.L., Inpatient antimicrobial stewardship in pediatrics: a systematic review. J Pediatric Infect Dis Soc 4 (2015), e127–35.
64. [64] Rubin, L.G., Tucci, V., Cercenado, E., Eliopoulos, G., Isenberg, H.D., Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 13 (1992), 700–705.
65. [65] Di Pentima, M.C., Chan, S., Impact of antimicrobial stewardship program on vancomycin use in a pediatric teaching hospital. Pediatr Infect Dis J 29 (2010), 707–711.
66. [66] Chavers, L.S., Moser, S.A., Benjamin, W.H., Banks, S.E., Steinhauer, J.R., Smith, A.M., et al. Vancomycin-resistant enterococci: 15 years and counting. J Hosp Infect 53 (2003), 159–171.
67. [67] Tamma, P.D., Hsu, A.J., Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children. Curr Opin Infect Dis 27 (2014), 517–527.
68. [68] Cheng, V.C.C., Chen, J.H.K., Tai, J.W.M., Wong, S.C.Y., Poon, R.W.S., Hung, I.F.N., et al. Decolonization of gastrointestinal carriage of vancomycin-resistant Enterococcus faecium: case series and review of literature. BMC Infect Dis, 14, 2014, 514.
69. [69] Banach, D.B., Peaper, D.R., Fortune, B.E., Emre, S., Dembry, L.M., The clinical and molecular epidemiology of pre-transplant vancomycin-resistant enterococci colonization among liver transplant recipients. Clin Transplant 30 (2016), 306–311.
70. [70] Carmeli, Y., Samore, M.H., Huskins, C., The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis. Arch Intern Med 159 (1999), 2461–2468.